Page 149 - சிலிக்கான் பள்ளத்தாக்கு அடிப்படையிலானது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

3 Min Read (Reuters) - Shares in Clover Health Investments Corp ended a seesaw trading session higher on Friday after the first public comment by its backer, venture capitalist Chamath Palihapitiya, on a critical report by short-selling specialist Hindenburg Research. Slideshow ( 2 images ) Clover said on Friday it would cooperate with an investigation by the U.S. Securities and Exchange Commission (SEC) into the Hindenburg report, which knocked Clover’s price down more than 12% on Thursday. The selling continued on Friday but a rebound came in late trade after Palihapitiya tweeted that he wished Hindenburg had contacted him or Clover so that it could have evaluated things first hand. He said he will let Clover’s long-term goals and performance speak for themselves.

New yorkUnited statesAnirban senMark potterVivek garipalliStephen culpChamath palihapitiyaSagarika jaisinghaniGamestop corpThomson reuters trust principlesExchange commissionClover health investments corpAlphabet incSequoia capitalHindenburg researchUs department of justice